30/09/20 9:15am
Zelira ZLD Signs Real-World Data Agreement for Insomnia Drug Zenivol™ with Emyria30 September 2020• Leverages Emyria’s clinical and data expertise to monitor the safety and efficacy of Zenivol™treatment in patients diagnosed with chronic insomnia • Real-world data will complement existing clinical data for Zenivol™ and inform path to further development and product registration• Data will add further value to the global commercialisation opportunities for Zenivol™• Partnership reinforces Zelira’s competitive advantage for bringing high-value cannabinoid medicines to market supported by clinical and real-world patient data
- Forums
- ASX - Day Trading
- Morning trading September 30
Morning trading September 30, page-2
-
- There are more pages in this discussion • 512 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)